UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Viveve Medical, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
04-3153858 |
(State of incorporation
|
|
(I.R.S. Employer
|
|
|
|
150 Commercial Street Sunnyvale, California |
|
94086 |
(Address of principal executive officers) |
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Name of each exchange on which
|
|
|
|
Common Stock, par value $0.0001 per share |
The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. [X]
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. [ ]
Securities Act registration statement file number to which this form relates: 333- 210816
Securities to be registered pursuant to Section 12(g) of the Act: None
Item 1. Description of Registrant’s Securities to be Registered.
Viveve Medical, Inc., a Delaware corporation (the “ Registrant ”), is registering hereunder its common stock, par value $0.0001 per share (the “ Common Stock ”). For a description of the Common Stock, reference is made to the information with respect to the Common Stock set forth under the heading “Description of Securities” contained in the Registrant’s Registration Statement on Form S-1 (File No. 333- 210816), as originally filed with the U.S. Securities and Exchange Commission (the “Commission”) on April 19, 2016, including exhibits thereto, as amended from time to time thereafter (the “ Registration Statement ”). In addition, the above-referenced description included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed incorporated herein by reference.
Item 2. Exhibits .
In accordance with the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are, or are to be, registered on The NASDAQ Stock Market LLC, and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Viveve Medical, Inc. |
||
|
|
|
Date: June 13, 2016 |
By: |
/s/ Patricia Scheller |
|
|
Patricia Scheller |
|
|
Chief Executive Officer |